Bone Biologics Corporation

NASDAQ (USD): Bone Biologics Corporation (BBLG)

Last Price

1.20

Today's Change

-0.12 (9.09%)

Day's Change

1.20 - 1.34

Trading Volume

106,175

Overview

Market Cap

2 Million

Shares Outstanding

2 Million

Avg Volume

3,050,684

Avg Price (50 Days)

1.64

Avg Price (200 Days)

1.88

PE Ratio

-0.07

EPS

-17.24

Earnings Announcement

12-Nov-2024

Previous Close

1.32

Open

1.27

Day's Range

1.2 - 1.3472

Year Range

0.8 - 10.56

Trading Volume

106,175

Price Change Highlight

1 Day Change

-9.09%

5 Day Change

-6.98%

1 Month Change

-28.14%

3 Month Change

-25.93%

6 Month Change

-37.50%

Ytd Change

-71.01%

1 Year Change

-70.00%

3 Year Change

-99.86%

5 Year Change

-99.96%

10 Year Change

-100.00%

Max Change

-100.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment